Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 6198526, 16 pages
https://doi.org/10.1155/2017/6198526
Research Article

Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population

1Unité de recherche UR12ES06, Physiologie de l’Exercice et Physiopathologie: de l’Intégré au Moléculaire “Biologie, Médecine et Santé,” Faculté de Médecine de Sousse, Université de Sousse, Sousse, Tunisia
2Faculté des Sciences de Bizerte, Université de Carthage, Bizerte, Tunisia
3Institut des Sciences Infirmières, Sousse, Tunisia
4District Medical du Centre, CNAM, Sousse, Tunisia
5Laboratory for Vascular Translational Science (LVTS), INSERM U1148, CHU X. Bichat, 46 rue Henri Huchard, 75877 Paris Cedex 18, France
6Faculté des Sciences de Sfax, Université de Sfax, Sfax, Tunisia

Correspondence should be addressed to Soumaya Boumiza; moc.liamg@azimuob.ayamuos

Received 2 July 2017; Revised 4 October 2017; Accepted 19 October 2017; Published 26 November 2017

Academic Editor: Michele Malaguarnera

Copyright © 2017 Soumaya Boumiza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. D. Apalasamy and Z. Mohamed, “Obesity and genomics: role of technology in unraveling the complex genetic architecture of obesity,” Human Genetics, vol. 134, no. 4, pp. 361–374, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Pereira, L. Teixeira, E. Aguilar et al., “Modulation of adipose tissue inflammation by FOXP3+ Treg cells, IL-10, and TGF-β in metabolically healthy class III obese individuals,” Nutrition, vol. 30, no. 7-8, pp. 784–790, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Berg, L. Schreier, and V. Miksztowicz, “Circulating and adipose tissue matrix metalloproteinases in cardiometabolic risk environments: pathophysiological aspects,” Hormone Molecular Biology and Clinical Investigation, vol. 17, no. 2, pp. 79–87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Gao and C. Bing, “Macrophage-induced expression and release of matrix metalloproteinase 1 and 3 by human preadipocytes is mediated by IL-1β via activation of MAPK signaling,” Journal of Cellular Physiology, vol. 226, no. 11, pp. 2869–2880, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ii, H. Yamamoto, Y. Adachi, Y. Maruyama, and Y. Shinomura, “Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis,” Experimental Biology and Medicine, vol. 231, no. 1, pp. 20–27, 2006. View at Publisher · View at Google Scholar
  6. J. T. Lee, N. Pamir, N. C. Liu et al., “Macrophage metalloelastase (MMP12) regulates adipose tissue expansion, insulin sensitivity, and expression of inducible nitric oxide synthase,” Endocrinology, vol. 155, no. 9, pp. 3409–3420, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Yan and D. D. Boyd, “Regulation of matrix metalloproteinase gene expression,” Journal of Cellular Physiology, vol. 211, no. 1, pp. 19–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Pereza, I. Plesa, A. Peterlin et al., “Functional polymorphisms of matrix metalloproteinases 1 and 9 genes in women with spontaneous preterm birth,” Disease Markers, vol. 2014, Article ID 171036, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Taylor, Y. V. Sun, J. Chu, T. H. Mosley, and S. L. Kardia, “Interactions between metallopeptidase 3 polymorphism rs679620 and BMI in predicting blood pressure in African–American women with hypertension,” Journal of Hypertension, vol. 26, no. 12, pp. 2312–2318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Jormsjö, C. Whatling, D. H. Walter, A. M. Zeiher, A. Hamsten, and P. Eriksson, “Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 11, pp. 1834–1839, 2008. View at Publisher · View at Google Scholar
  11. L. Joos, J. Q. He, M. B. Shepherdson et al., “The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function,” Human Molecular Genetics, vol. 11, no. 5, pp. 569–576, 2002. View at Publisher · View at Google Scholar
  12. World Health Organization, October 2017, http://www.who.int/mediacentre/factsheets/fs311/en/.
  13. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar
  14. H. Miâdi-Messaoud, A. Chouchane, E. Abderrazek et al., “Obesity-induced impairment of endothelium-dependent vasodilation in Tunisian women,” International Journal of Obesity, vol. 34, no. 2, pp. 273–279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Dimassi, K. Chahed, S. Boumiza et al., “Role of ENOS- and NOX-containing microparticles in endothelial dysfunction in patients with obesity,” Obesity, vol. 24, no. 6, pp. 1305–1312, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. H. B. Nasr, S. Dimassi, R. M'hadhbi et al., “Functional G894T (rs1799983) polymorphism and intron-4 VNTR variant of nitric oxide synthase (NOS3) gene are susceptibility biomarkers of obesity among Tunisians,” Obesity Research & Clinical Practice, vol. 10, no. 4, pp. 465–475, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Anari, R. Amani, S. M. Latifi, M. Veissi, and H. Shahbazian, “Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 11, no. 1, pp. 37–41, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. N. HalbergI. Wernstedt-Asterholm and P. E. Scherer, “The adipocyte as an endocrine cell,” Endocrinology and Metabolism Clinics of North America, vol. 37, no. 3, pp. 753–768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Chavey, B. Mari, M. N. Monthouel et al., “Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation,” Journal of Biological Chemistry, vol. 278, no. 14, pp. 11888–11896, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Eser, O. Eser, Y. Yuksel et al., “Effects of MMP-1 and MMP-3 gene polymorphisms on gene expression and protein level in lumbar disc herniation,” Genetics and Molecular Research, vol. 15, no. 3, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Collazos, V. Asensi, G. Martin, A. H. Montes, T. Suárez-Zarracina, and E. Valle-Garay, “The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions,” Clinical & Experimental Immunology, vol. 182, no. 2, pp. 213–219, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. A. O’Hara, F.-L. Lim, D. J. Mazzatti, and P. Trayhurn, “Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium,” Pflügers Archiv - European Journal of Physiology, vol. 458, no. 6, pp. 1103–1114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Melekoglu, O. Ciftci, S. Eraslan, N. Basak, and E. Celik, “The effects of body mass index on second-trimester amniotic fluid cytokine and matrix metalloproteinase levels,” Gynecologic and Obstetric Investigation, 2017. View at Publisher · View at Google Scholar
  24. M. H. Hsieh, P. C. Chou, C. L. Chou et al., “Matrix metalloproteinase-1 polymorphism (−1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan,” PLoS One, vol. 8, no. 6, article e66265, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Pearce, D. A. Tregouet, A. Samnegård et al., “Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction,” Circulation Research, vol. 97, no. 10, pp. 1070–1076, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. H. L. Huang, S. Wu, L. A. Hsu et al., “Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity,” BMC Medical Genetics, vol. 14, no. 1, p. 30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Kępczyńska, M. S. Zaibi, S. Y. Alomar, and P. Trayhurn, “PCR arrays indicate that the expression of extracellular matrix and cell adhesion genes in human adipocytes is regulated by IL-1β (interleukin-1β),” Archives of Physiology and Biochemistry, vol. 123, no. 1, pp. 61–67, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Li, J. Shi, L. Fu, H. Wang, B. Zhou, and X. Wu, “Genetic polymorphism of MMP family and coronary disease susceptibility: a meta-analysis,” Gene, vol. 495, no. 1, pp. 36–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Qi, H. Zhao, Y. Wang et al., “Genetic variants of the matrix metalloproteinase family genes and risk for hypertension: a case–control study among northeastern Han Chinese,” Hypertension Research, vol. 37, no. 10, pp. 944–949, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. B. D. Freimark, W. S. Feeser, and S. A. Rosenfeld, “Multiple sites of the propeptide region of human stromelysin-1 are required for maintaining a latent form of the enzyme,” Journal of Biological Chemistry, vol. 269, no. 43, pp. 26982–26987, 1994. View at Google Scholar
  31. M. T. Traurig, P. A. Permana, S. Nair, S. Kobes, C. Bogardus, and L. J. Baier, “Differential expression of matrix metalloproteinase 3 (MMP3) in preadipocytes/stromal vascular cells from nonobese nondiabetic versus obese nondiabetic Pima Indians,” Diabetes, vol. 55, no. 11, pp. 3160–3165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Nakai, H. Tanaka, K. Yamanaka et al., “Effects of C-reactive protein on the expression of matrix metalloproteinases and their inhibitors via Fcγ receptors on 3T3-L1 adipocytes,” International Journal of Medical Sciences, vol. 14, no. 5, pp. 484–493, 2017. View at Publisher · View at Google Scholar
  33. G. A. Preston, C. V. Barrett, D. A. Alcorta et al., “Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels,” Nephron, vol. 92, no. 4, pp. 817–823, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Hui, G. J. Litherland, M. S. Elias et al., “Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases,” Annals of the Rheumatic Diseases, vol. 71, no. 3, pp. 455–462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Derosa, I. Ferrari, A. D'Angelo et al., “Matrix metalloproteinase-2 and -9 levels in obese patients,” Endothelium, vol. 15, no. 4, pp. 219–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Gummesson, D. Hägg, F. J. Olson, J. Hulthe, L. M. Carlsson, and B. Fagerberg, “Adipose tissue is not an important source for matrix metalloproteinase-9 in the circulation,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 69, no. 6, pp. 636–642, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Miksztowicz, N. Fernandez Machulsky, D. Lucero, E. Fassio, L. Schreier, and G. Berg, “Adiponectin predicts MMP-2 activity independently of obesity,” European Journal of Clinical Investigation, vol. 44, no. 10, pp. 951–957, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Kurki, J. Shi, E. Martonen, P. Finckenberg, and E. Mervaala, “Distinct effects of calorie restriction on adipose tissue cytokine and angiogenesis profiles in obese and lean mice,” Nutrition & Metabolism, vol. 9, no. 1, p. 64, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Agnihotri, H. C. Crawford, H. Haro, L. M. Matrisian, M. C. Havrda, and L. Liaw, “Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin),” Journal of Biological Chemistry, vol. 276, no. 30, pp. 28261–28267, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Fujishima, T. Shiomi, S. Yamashita et al., “Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis,” Archives of Pathology & Laboratory Medicine, vol. 134, no. 8, pp. 1136–1142, 2010. View at Google Scholar
  41. E. Maquoi, C. Munaut, A. Colige, D. Collen, and H. R. Lijnen, “Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity,” Diabetes, vol. 51, no. 4, pp. 1093–1101, 2002. View at Publisher · View at Google Scholar
  42. P. J. Yang, K. H. Ser, M. T. Lin et al., “Diabetes associated markers after bariatric surgery: fetuin-A, but not matrix metalloproteinase-7, is reduced,” Obesity Surgery, vol. 25, no. 12, pp. 2328–2334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Kesh, L. Subramanian, and N. Ghosh, “Association of MMP7 -181A→G promoter polymorphism with gastric cancer risk: influence of nicotine in differential allele-specific transcription via increased phosphorylation of cAMP-response element-binding protein (CREB),” Journal of Biological Chemistry, vol. 290, no. 23, pp. 14391–14406, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Alp, A. Yilmaz, M. Tulmac et al., “Analysis of MMP-7 and TIMP-2 gene polymorphisms in coronary artery disease and myocardial infarction: a Turkish case-control study,” Kaohsiung Journal of Medical Sciences, vol. 33, no. 2, pp. 78–85, 2017. View at Publisher · View at Google Scholar
  45. T. J. Richards, C. Park, Y. Chen et al., “Allele-specific transactivation of matrix metalloproteinase 7 by FOXA2 and correlation with plasma levels in idiopathic pulmonary fibrosis,” American Journal of Physiology Lung Cellular and Molecular Physiology, vol. 302, no. 8, pp. 746–754, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. E. A. Kastelijn, C. H. van Moorsel, H. J. Ruven et al., “Genetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantation,” The Journal of Heart and Lung Transplantation, vol. 29, no. 6, pp. 680–686, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Ress, A. Tschoner, C. Ciardi et al., “Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels,” European Cytokine Network, vol. 21, no. 1, pp. 65–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. C. G. Bell, A. J. Walley, and P. Froguel, “The genetics of human obesity,” Nature Reviews Genetics, vol. 6, no. 3, pp. 221–234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Amor, V. Moreno-Viedma, A. Sarabi et al., “Identification of matrix metalloproteinase-12 as a candidate molecule for prevention and treatment of cardiometabolic disease,” Molecular Medicine, vol. 22, pp. 487–496, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. V. E. de Meijer, D. Y. Sverdlov, H. D. Le, Y. Popov, and M. Puder, “Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity,” Hepatology Research, vol. 42, no. 6, pp. 601–610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Motterle, Q. Xiao, S. Kiechl et al., “Influence of matrix metalloproteinase-12 on fibrinogen level,” Atherosclerosis, vol. 220, no. 2, pp. 351–354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Shimizu, T. Matsubara, Y. Onouchi et al., “Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease,” Journal of Human Genetics, vol. 55, no. 12, pp. 779–784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Pérez-Hernández, G. Vargas-Alarcón, N. Martínez-Rodríguez et al., “The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients,” Journal of Atherosclerosis and Thrombosis, vol. 19, no. 8, pp. 718–727, 2012. View at Google Scholar
  54. S. Jormsjö, S. Ye, J. Moritz et al., “Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease,” Circulation Research, vol. 86, no. 9, pp. 998–1003, 2000. View at Publisher · View at Google Scholar
  55. M. Villalobos-Comparán, H. Villamil-Ramírez, T. Villarreal-Molina et al., “PCSK1 rs6232 is associated with childhood and adult class III obesity in the Mexican population,” PLoS One, vol. 7, no. 6, article e39037, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. P. León-Mimila, H. Villamil-Ramírez, M. Villalobos-Comparán et al., “Contribution of common genetic variants to obesity and obesity-related traits in Mexican children and adults,” PLoS One, vol. 8, no. 8, article e70640, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. F. F. Carlos, J. Silva-Nunes, O. Flores et al., “Association of FTO and PPARG polymorphisms with obesity in Portuguese women,” Diabetes, Metabolic Syndrome and Obesity, vol. 6, pp. 241–245, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. H. H. Chen, W. J. Lee, W. Wang, M. T. Huang, Y. C. Lee, and W. H. Pan, “Ala55Val polymorphism on UCP2 gene predicts greater weight loss in morbidly obese patients undergoing gastric banding,” Obesity Surgery, vol. 17, no. 7, pp. 926–933, 2007. View at Publisher · View at Google Scholar · View at Scopus